Founder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Zoe Bedford Karli, our President and a Director, officially joined the Greyledge executive team in 2019.
VP of Operations
Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.
Howard Ash is an accomplished Executive with extensive experience in business and finance, who served as CEO, COO, and CFO to a variety of high-profile, international companies.
Mr. Mansour has been actively involved with disruptive technology as an inventor, manager, executive, and coach for more than 3 decades. He has extensive experience within many sectors – Bio-Technology, Consumer Electronics, Computer Science, Energy, Health Sciences, Hospitality, and Publishing. He has spoken often throughout his career on the future of technology and the effects of its disruption.